Results 11 to 20 of about 181,328 (267)

Low cardiac output syndrome in cardiac surgery

open access: yesAlʹmanah Kliničeskoj Mediciny, 2019
Low cardiac output syndrome is one of the most common and serious complications in cardiac surgery and is associated with increased morbidity and mortality.
D. N. Merekin   +4 more
doaj   +3 more sources

PERIOPERATIVE USE OF LEVOSIMENDAN IN PATIENTS WITH SEVERE LEFT VENTRICULAR DYSFUNCTION UNDERGOING CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS [PDF]

open access: yesAin Shams Medical Journal, 2022
Background: Levosimendan is a calcium-sensitizing ionodilator. However, the current level of clinical evidence is insufficient to determine the clinical value of levosimendan in patients with severe left ventricular dysfunction subjected to cardiac ...
Ramy Reda   +3 more
doaj   +1 more source

Euvolemic off pump coronary surgery further improves early postoperative outcomes

open access: yesAnnals of Cardiac Anaesthesia, 2022
Background: Fluid resuscitation during Off-Pump Coronary Surgery (OPCABG) is still not protocolized and depends on multiple variables. We are exploring in this study whether a restrictive or euvolemic approach has any impact on short term surgical ...
Kaushalendra Rathore   +4 more
doaj   +1 more source

Cardiorenal syndrome type I recovery following heart rate correction: Cardiac output is not only stroke volume

open access: yesClinical Case Reports, 2022
Bradyarrhymias can result in low cardiac output state despite having a normal left ventricular ejection fraction and stroke volume. Because cardiac output is defined as the product of heart rate and stroke volume, a low cardiac output state caused by ...
Ossama Maadarani   +6 more
doaj   +1 more source

INDUCED MODERATE HYPOTHERMIA FOR LOW CARDIAC OUTPUT AFTER PEDIATRIC CARDIAC SURGERY [PDF]

open access: yesActa Medica Iranica, 2008
"nPostoperative low cardiac output states are a major cause of postoperative mortality in infants and children following corrective cardiac surgery or congenital heart defects.
P Akbari-Asbagh, M. A Navabi
doaj   +2 more sources

Comparison of Levosimendan, Milrinone and Dobutamine in treating Low Cardiac Output Syndrome Following Valve Replacement Surgeries with Cardiopulmonary Bypass [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: Low Cardiac Output Syndrome (LCOS) following Cardiopulmonary Bypass (CPB) is common and associated with increased mortality. Maintenance of adequate cardiac output is one of the primary objectives in management of such patients. Aim: To
Sunny   +5 more
doaj   +1 more source

Prediction of low cardiac output syndrome in patients following cardiac surgery using machine learning

open access: yesFrontiers in Medicine, 2022
BackgroundThis study aimed to develop machine learning models to predict Low Cardiac Output Syndrome (LCOS) in patients following cardiac surgery using machine learning algorithms.MethodsThe clinical data of cardiac surgery patients in Nanjing First ...
Liang Hong   +7 more
doaj   +1 more source

Predictors of low cardiac output after isolated pericardiectomy: an observational study

open access: yesPerioperative Medicine, 2022
Background Low cardiac output is the main cause of perioperative death after pericardiectomy for constrictive pericarditis. We investigated the associated risk factors and consequences.
Jin Wang   +6 more
doaj   +1 more source

Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01

open access: yesFrontiers in Pharmacology, 2020
BackgroundLow-cardiac output syndrome (LCOS) after cardiac surgery secondary to systemic hypoperfusion is associated with a higher incidence of renal and neurological damage. A range of effective therapies are available for LCOS.
Jose L. Guerrero-Orriach   +35 more
doaj   +1 more source

Successful use of levosimendan as a primary inotrope in pediatric cardiac surgery: An observational study in 110 patients

open access: yesAnnals of Pediatric Cardiology, 2016
Context: Levosimendan is a new generation inotrope with calcium sensitizing properties and proven benefits in adults. Aims: This study investigates the use of levosimendan as a first line inotrope in congenital heart surgery.
Reena Khantwal Joshi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy